Results 41 to 50 of about 375,685 (295)

Self-reported problems by patients suffering from Rheumatic Fever and Rheumatic Heart Disease in five domains of EQ-5D-5L.

open access: yes, 2021
Self-reported problems by patients suffering from Rheumatic Fever and Rheumatic Heart Disease in five domains of EQ-5D-5L.
Gaurav Jyani (9327725)   +3 more
core   +1 more source

Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS‐DAI)

open access: yesArthritis Care &Research, EarlyView.
Objective Vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic syndrome (VEXAS) syndrome is characterized by a complex spectrum of inflammatory and hematologic manifestations. Clinical research to identify effective therapies is urgently needed but is hindered by the lack of validated outcome measures.
Kevin Byram   +25 more
wiley   +1 more source

Clinical Characteristics and Concordance of Anti‐MDA5 Antibodies: A Multicenter Australian Study

open access: yesArthritis Care &Research, EarlyView.
Objective In Australia, anti‐MDA5 antibodies are exclusively tested by a line immunoblot assay (LIA). The clinical concordance of an LIA‐positive anti‐MDA5 result is unclear. We aimed to describe the clinical features and determine the clinical concordance of patients with anti‐MDA5 antibodies. Methods Electronic records of a multisite cohort (patients
Syed B. Ali   +11 more
wiley   +1 more source

Rheumatic heart disease in Tennessee: An overlooked diagnosis

open access: yesSAGE Open Medical Case Reports, 2014
Rheumatic heart disease, already a major burden in low- and middle-income countries, is becoming an emerging problem in high-income countries. Although acute rheumatic fever and rheumatic heart disease have almost been eradicated in areas with ...
Shahana A Choudhury, Vernat Exil
doaj   +1 more source

Erythema marginatum: an uncommon presentation of acute rheumatic fever in a Nigerian adolescent girl—a case report

open access: yesEgyptian Pediatric Association Gazette, 2021
Background Erythema marginatum is an uncommon presentation in children with acute rheumatic fever and it is one of the major criteria needed to make a diagnosis. It is seen in less than 10% of cases. It is also reported to be difficult to detect in black-
Barakat Adeola Animasahun   +2 more
doaj   +1 more source

Incidence, Risk Factors and Management of Adverse Events in Contemporary Real‐World Care of Children with Juvenile Idiopathic Arthritis

open access: yesArthritis Care &Research, Accepted Article.
Objective We describe the frequency, risk factors, severity, and management of actionable and serious adverse events (AAE and SAE) in children with newly diagnosed Juvenile Idiopathic Arthritis (JIA) in Canada. Methods We enrolled patients within 3 months of JIA diagnosis in the Canadian Alliance of Pediatric Rheumatology Investigators (CAPRI) Registry,
Bashayer Alnuaimi   +10 more
wiley   +1 more source

Blood pressure levels among the studentsof a selected school

open access: yesIMC Journal of Medical Science, 2010
In Bangladesh, limited data are available on paediatric hypertension as well as their normal values. This study was done to assess the level of blood pressure in this population group.
Abdullah Al-Shafi Mazumder   +5 more
doaj  

Ressurgimento da febre reumática. Novas causas ou velhas atitudes?

open access: yesActa Médica Portuguesa, 1996
Bearing in mind that in the last years there has been an increase in rheumatic fever episodes, the authors evaluate the cases recently observed in the department.
M J Brito   +9 more
doaj   +1 more source

Rheumatic Fever

open access: yes, 2016
Chapter 6 of Clinical Notes on Disorders of Childhood. In this chapter, Winnicott introduces the nature and chief manifestations of rheumatic fever He contends that but for the possible complication of heart disease, rheumatic arthritis could be left to ...
Donald W. Winnicott
core   +1 more source

Engineering Approaches to Modify Immunomodulatory Functions of Mesenchymal Stromal Cells (MSCs): Tissue Regeneration and Clinical Application

open access: yesAdvanced Science, EarlyView.
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy